Results 81 to 90 of about 3,060,700 (298)

Matrix structure for supporting organisational innovation capability [PDF]

open access: yes, 2013
The importance of an organisation's capability to produce innovations has been noticed to be increasingly important. Previous literature has discussed appropriate organisational structures for innovation activities. The matrix structure is widely seen to
Mäkimattila, Martti   +2 more
core   +1 more source

Synthetic single‐domain antibodies as immunoconjugate therapeutics

open access: yesFEBS Letters, EarlyView.
Single‐domain antibodies (sdAbs), at about one‐tenth the size of conventional antibodies, overcome the traditional barrier of deeper penetration into tumors. Their small footprint and ease of engineering facilitate transport of cytotoxic payloads or radionuclides directly to cancer cells.
Robbins Puthenveetil   +8 more
wiley   +1 more source

Technological intensity and innovation capability in industrial firms [PDF]

open access: yes, 2018
Purpose – Over time, technological intensity has been used as a proxy for innovation capability of firms in an industrial sector. However, not only firms belonging to the stratum of high technological intensity are able to innovate. Therefore, this study
Tello-Gamarra, Jorge   +6 more
core   +2 more sources

Winning by Intelligence: Leveraging the Innovative Advantages of Intelligent Transformation in Market Competition

open access: yesSystems
Intelligent transformation plays an important role in enhancing innovation capabilities. This study utilizes data from 5000 A-share firms in China to investigate the effects of intelligent transformation on innovation capability and to elucidate the ...
Jingwen Lv, Lu Feng, Wei Xiao, Wei He
doaj   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

China's Regional Inequality in Innovation Capability, 1995-2004 [PDF]

open access: yes
Relying on a recently developed decomposition framework, this paper explores spatial distribution of innovation capability in China. It is found that at the regional level, China's inequality in innovation capability increased from 1995 to 2004.
Fan, Peilei, Wan, Guanghua
core  

Market orientation, innovation capability and business performance

open access: yes, 2014
Innovation management has become a crucial strategic task for companies in their efforts to achieve organizational effectiveness. For instance, organizations manage innovation-related activities in order to maintain their market positions and/or assure ...
Huhtala, Juho-Petteri   +10 more
core   +1 more source

Structural Capability of an Organization toward Innovation Capability [PDF]

open access: yes, 2016
The scholars in the field of strategic management have developed two major approaches for attainment of competitive advantage: an approach based on environmental opportunities, and another one based on internal capabilities of an organization.
Momeni, Mostafa   +1 more
core   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy